Press releases
February 26, 2025
PathMaker Neurosystems Welcomes Pritesh Shah to Board of Directors
February 4, 2025
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator® Device in ALS
September 20, 2024
PathMaker Neurosystems Appoints Industry Veteran John Fletcher as Chairman of Company’s Board of Directors
June 5, 2024
PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial
September 14, 2023
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
June 5, 2023
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
January 17, 2023
Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
June 8, 2022
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
February 7, 2022
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
October 21, 2021
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
September 27, 2021
PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
September 20, 2021
PathMaker Neurosystems Announces Receipt of NIH Grant For Application of its Non-Invasive Neuromodulation Technology to Amyotrophic Lateral Sclerosis (ALS)
June 26, 2019
PathMaker Neurosystems is Named as Recipient of France’s Top Prize for Innovation